Galera Therapeutics Inc.
13F holders, Q1 2026 (March 31)1holders
1new positions
0sold out
$0.04avg. 13F price*
At the end of Q1 2026, 1 institutions reported holding Galera Therapeutics Inc. in their 13F filings, unchanged from Q2 2024. 1 opened new positions and 0 sold out. The largest holder was Ascentis Independent Advisors ($4).
- Company
- Galera Therapeutics Inc.
- CUSIP
- 36338D108
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $4 |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q1 2026: 93 shares bought, net +93 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Ascentis Independent Advisors | 0.00% | New | 93 | $4 |
"% of holder's portfolio" is GALERA THERAPEUTICS INC's weight in each manager's 13F, not the share of Galera Therapeutics Inc. the manager owns.